One stock yields 6% today. Another has grown its dividend by 460% over the past decade. Both are blue chip bargains to buy right now.

If you're looking for an undervalued growth stock to buy right now, Pfizer (NYSE: PFE) is an investment that should be near ...

They found that mRNA vaccines that target C. diff cells and the toxins they produce generated a lasting immune response in mice and hamsters.

An influx of late-phase programs has prompted Genmab to reassess its bets. | An influx of late-phase programs has prompted Genmab to reassess its bets. The biotech is axing three early-stage clinical ...

Androgenetic alopecia (AGA) is the leading cause of hair loss in both men and women. Experts outline current and emerging therapies in ...

Pharmaceutical giant Pfizer has agreed to pay $35 million to settle allegations that it unlawfully hindered the sale of Lipitor, a drug prescribed to lower ...

Meanwhile, among the sector's biggest decliners were hospital operators, with HCA Healthcare Inc.'s stock (HCA) shedding 4.6%, Universal Health Services Inc. shares (UHS) falling 3.7% and shares of ...

The stock market is celebrating Donald Trump’s presidential election victory. The Dow Jones Industrial Average roared higher ...

What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first ...

Is India’s booming healthcare market part of your strategy, or are you overlooking a crucial opportunity? This is a question that U.S. healthcare companies should be pondering as India’s health and ...

Rather than bribing and wheedling physicians to pretty-please-prescribe-our-drug, websites allow companies to deal drugs ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...